Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

NCT07184853 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Graft vs Host Disease

Interventions

DRUG: Ruxolitinib (JAKAVI®)
DRUG: Etanercept (Enbrel)

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]